Join Stanford Biodesign to hear from two of the Stanford-India Biodesign initiative’s architects and an early alumna. How did they lay the groundwork for the program? What are the opportunities and challenges inherent in a collaboration with the government? How did the need for cost-effective technologies influence the innovation approach? And how did they catalyze the work of funders, suppliers, manufacturers, distributors, and purchasers required to get the inventions to patients? They will discuss their biggest takeaways from this entrepreneurial endeavor, the potential to replicate it in other resource-constrained environments, and what excites them most about the future of healthtech innovation in India.
